EDITH HERGAN: Open Payments
NPI 1326016726 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 40 payments from 10 companies in 2025. Trend: 2023 $76 · 2024 $212 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Alkermes, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Indivior Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| TMS NeuroHealth Centers Inc. | 1 | $16 |
Products named: VRAYLAR, TRINTELLIX, SPRAVATO, COBENFY, REXULTI, FANAPT, SUBLOCADE, ARISTADA.
Industry payments across CT — which companies pay providers there.
